Medical Marijuana Market is Growing at a CAGR of 26.4%, and the Growth is Influenced by Medical Application of Marijuana as Pain Management in Cancer, Seizures, Neurology and Muscle Spasms | Reports and Data

Press Release • updated: Sep 17, 2019
Market Size - USD $11.70 Billion in 2018, Market Growth - CAGR of 26.4%, Market Trends - Legalization of Marijuana in Several Countries
Reports and Data

NEW YORK, September 17, 2019 (Newswire.com) - ​Medical application of marijuana as pain management in cancer, seizures, neurology, and muscle spasms will drive the market growth.

The Global Medical Marijuana Market is forecast to reach USD $148.35 billion by 2026, according to a new report by Reports and Data. Marijuana is used for treating chronic pain, which affects millions of people each year across the globe, thus increasing the demand for the product as a treatment procedure for medical conditions. Statistically, around 25 million people endure acute pain in the US. Moreover, several countries around the globe have made medical marijuana legal, i.e., it would allow people to use marijuana for health purposes, therefore, boosting the market for the medical marijuana market.

Request a free sample of this research report at: https://www.reportsanddata.com/sample-enquiry-form/1413

Side effects of the products include dizziness, fatigue, speech problem, constipation and insomnia and will hamper the growth of the market. Additionally, lack of data safety and problems in undertaking a medical marijuana business is also estimated to hinder the growth of the market.

North America dominates the market of medical marijuana. The major contributors are the U.S. and Canada. As of 2018, 30 U.S. states have permitted the application of medical marijuana. Moreover, the growing number of research studies in the U.S., encouraging and supporting marijuana's use for medical purposes, will supplement the North American medical marijuana market's growth.

In 2017, Oxford University went into a partnership with Kingsley Capital Partners for the development of cannabis treatment for inflammatory and cancer diseases. These partnerships are expected to have a positive impact on the market of medical marijuana.

Further key findings from the report suggest

  • Countries are beginning to liberalize laws related to medical marijuana; the market is forecast to witness a surge in demand. Statistically, the majority of cannabis is currently sold through illicit channels.
     
  • Several countries have recognized the advantages of this product and are in the process of legalizing it.
     
  • With a rise in the volume of clinical trials and scientific studies, the demand for cannabis for clinical use is forecast to grow over the forecast period. Medical marijuana held a market share of 53% in the year 2018.
     
  • Countries in North America have also started promoting derivatives such as oils, tinctures, and resins, along with products like vaporizers, among millennials, who are considered primary consumers.
     
  • The oil segment is forecast to grow, with the highest CAGR of 27.1% in the forecast period. Hemp oil is in high demand among the healthcare sector for clinical purposes.
     
  • Health concerns associated with smoking is another factor that stops doctors from prescribing it. Hence, oil or edible forms of marijuana are generally prescribed and are growing in demand.
     
  • On the basis of application, the market is segmented into Chronic Pain, Mental Disorders, Anorexia, Seizures, Muscle Spasms, Cancers, and Other.
     
  • Chronic pain dominated the market, with a share of 63% in the year 2018. Marijuana reduced pain and also improved the quality of life among patients.
     
  • On the basis of the route of administration, the inhalation segment is forecast to have the highest market share of 54% in the year 2026.
     
  • Inhalation provides an advantage of controlled dosage and effective absorption of cannabinoids into the body. This should increase the demand for inhalation marijuana over the coming years.
     
  • Dispensaries held a market share of 48% in the year 2018. These pharmacies sell various legal cannabis products in the form of tablets, vaporizers, balms, elixirs and tinctures.
     
  • Patients usually prefer buying medical products from authorized and legal sources to abide by the government’s rules, thus maximizing the revenue by this segment.
     
  • Europe is forecast to have a market share of 28% in the year 2026. Germany is the largest market for cannabis and, thereby, fuels the growth of the market in this region.
     
  • Key participants Canopy Growth Corporation, Aphria, Inc., Aurora Cannabis, Maricann Group, Inc., Tilray, Cronos Group, Organigram Holdings, Inc., ABcann Medicinals, Inc., Tikun Olam, Insys Therapeutics, Inc., The Peace Naturals Project, MedReleaf Corporation, and GW Pharmaceuticals PLC.

To identify the key trends in the industry, click on the link below:   https://www.reportsanddata.com/report-detail/medical-marijuana-market

Segments covered in the report:

For the purpose of this report, Reports and Data have segmented the global Medical Marijuana Market on the basis of Marijuana Type, Product Type, Route of Administration, Distribution Channel, Medical Application, and Region:                       

Marijuana Type Outlook (Revenue, USD Billion; 2016-2026)

  • Medical Marijuana
  • Recreational Marijuana

Product Type Outlook (Revenue, USD Billion; 2016-2026)

  • Oil
  • Buds
  • Tinctures

Medical Application Outlook (Revenue, USD Billion; 2016-2026)

  • Chronic Pain
  • Mental Disorders
  • Anorexia
  • Seizures
  • Muscle Spasms
  • Cancers
  • Other

Route of Administration Outlook (Revenue, USD Billion; 2016-2026)

  • Inhalation
  • Oral
  • Intravenous
  • Topical

Distribution Channel Outlook (Revenue, USD Billion; 2016-2026)

  • Dispensaries
  • Online

Order Now: https://www.reportsanddata.com/checkout-form/1413

Regional Outlook (Revenue, USD Million; 2016-2026)

  • North America
    • U.S.
  • Europe
    • U.K.
    • France
  • Asia Pacific
    • China
    • India
    • Japan
  • MEA
  • Latin America
    • Brazil

Browse more reports of Pharmaceutical category at:  https://www.reportsanddata.com/report/category/pharma-and-healthcare

About Reports and Data 

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help clients make smarter business decisions. We offer market intelligence studies, ensuring relevant and fact-based research across multiple industries, including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existing in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John Watson
Head of Business Development
​Reports And Data | Web: www.reportsanddata.com
​Direct Line: +1-800-819-3052
Email: sales@reportsanddata.com

Source: Reports and Data

Tags

About Reports and Data

More Press Releases